| PubMed |
Abstract |
RScore(About this table) |
| 15717129 |
Park Y, Hahm KS: Effects of N- and C-terminal truncation of HP (2-20) from Helicobacter pylori ribosomal protein L1 (RPL1) on its anti-microbial activity. Biotechnol Lett. 2005 Feb;27(3):193-9.
|
2(0,0,0,2) |
Details |
| 15358153 |
Park Y, Park SN, Park SC, Park JY, Park YH, Hahm JS, Hahm KS: Antibiotic activity and synergistic effect of antimicrobial peptide against pathogens from a patient with gallstones. Biochem Biophys Res Commun. 2004 Aug 27;321(3):631-7.
HP (2-20) is a peptide derived from the N-terminus of Helicobacter pylori ribosomal protein L1 that has been shown to have antimicrobial activity against various species of bacteria. |
1(0,0,0,1) |
Details |
| 12359236 |
Lee DG, Park Y, Kim PI, Jeong HG, Woo ER, Hahm KS: Influence on the plasma membrane of Candida albicans by HP (2-9)-magainin 2 (1-12) hybrid peptide. Biochem Biophys Res Commun. 2002 Oct 4;297(4):885-9.
A 20-residue hybrid peptide (HP (2-9)-MA (1-12): HP-MA), incorporating 2-9 residues of Helicobacter pyroli ribosomal protein L1 (HP) and 1-12 residues of magainin 2 (MA), has more potent antibacterial activity than parent peptide HP (2-20) and magainin 2. |
1(0,0,0,1) |
Details |